There are 2 sources of cholesterol. Food & Family.

Only Vytorin treats both.

Brand name: Vytorin
Generic name/category: Ezetimibe/simvastatin, Statins
Company: Merck/Schering-Plough Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: treatment of dyslipidemia
Target: Consumers (DTC)
Tagline: Treat the 2 sources of cholesterol
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Prevention – December 2009

To see all of this brand's ads on AdPharm, click here

Ezetimibe/simvastatin is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (best known as Zetia in the United States and Ezetrol elsewhere) and the statin drug simvastatin (best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co./Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.

Ezetimibe reduces blood cholesterol by inhibiting absorption of cholesterol by the small intestine by acting at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.

Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click on thumbnail to view the full-size ad on AdPharm

There are 2 sources of cholesterol. Food & Family.

Only Vytorin treats both.

Brand name: Vytorin
Generic name/category: Ezetimibe/simvastatin, Statins
Company: Merck/Schering-Plough Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: treatment of dyslipidemia
Target: Consumers (DTC)
Tagline: Treat the 2 sources of cholesterol
Medium: Print ad
Size/duration: single-page
Publication/Aired: USA News & World Report – October 2009

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

For Major Depressive Disorder (MDD)
Lexapro is now approved for adolescents aged 12 to 17
Lexapro provides symptom relief for adolescents with MDD.

Brand name: Lexapro
Generic name/category: Escitalopram, Enantiopure drugs, Nitriles, Selective serotonin reuptake inhibitors (SSRI)
Company: Forest Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: Adolescents with Major Depressive Disorder (MDD)
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: Four-page spread
Publication/Aired: Drug Topics – August 2009

To see all of this brand’s ads on AdPharm, click here

Take IV iron therapy to a proven place:
Response with toleration!

The only first-line IV iron for pre-dialysis CKD patients…

Venofer (iron sucrose injection) is a complex of polynuclear iron (III)-hydroxide in sucrose. It is approved for use in replenishing iron in patients receiving erythropoietin (a hormone that stimulates red blood cell production) and undergoing chronic hemodialysis, which involves filtering the blood in order to remove waste products. In these patients, an iron deficiency is caused by blood loss during the dialysis procedure, increased erythropoiesis (red blood cell production), and insufficient absorption of iron from the gastrointestinal tract. Iron is essential for the synthesis of hemoglobin, which is responsible for the transport of oxygen throughout the body.

More on Medilexicon

Brand name: Venofer
Generic name/category: iron sucrose injection
Company: American Regent
Country/Market: USA, North America
Indication(s)/use: replenishing iron in patients receiving erythropoietin (a hormone that stimulates red blood cell production) and undergoing chronic hemodialysis
Target: Healthcare Professionals (HCP)
Tagline: Reinvigorating anemia management.
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Blood – August 13, 2009
1 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads

Now, a pill that comes with a plan.
Get the full picture in OAB care

Toviaz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency

Fesoterodine (INN, brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome. It was approved by the European Medicines Agency in April 2007 and was approved by the US Food and Drug Administration on October 31, 2008.

Fesoterodine is a prodrug. It is broken down into its active metabolite, 5-hydroxymethyl tolterodine, by plasma esterases.

More on Wikipedia

Brand name: Toviaz
Generic name/category: Fesoterodine, Muscarinic antagonists, Prodrugs
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Overactive bladder OAB
Target: Healthcare Professionals (HCP)
Tagline: Get the full picture in OAB care
Medium: Print ad
Size/duration: single-page
Publication/Aired: Urology Times – September 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 07, 2009

Visit AdPharm.net for more pharmaceutical ads

There are 2 sources of cholesterol. Food & Family.

Only Vytorin treats both.

Brand name: Vytorin
Generic name/category: Ezetimibe/simvastatin, Statins
Company: Merck/Schering-Plough Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: treatment of dyslipidemia
Target: Consumers (DTC)
Tagline: Treat the 2 sources of cholesterol
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Prevention – October 2009

To see all of this brand’s ads on AdPharm, click here

When it comes to your health, knowledge is the best medicine.

Our 20,000 employees are committed to the research and development of new medicines and vaccines and making them available to Canadians. These discoveries help you care for your family and loved ones. But all the discoveries cannot replace a healthy lifestyle. To find out about how our involvement goes beyond our discoveries, visit www.canadapharma.org

Canada’s Research-Based Pharmaceutical Companies. Les compagnies de recherche pharmaceutique du Canada.

Generic name/category: Corporate awareness
Company: R & D Canada
Country/Market: Canada, North America
Indication(s)/use: Healthcare research
Target: Consumers (DTC) / Healthcare Professionals (HCP)
Publication: Canadian Health Summer 2009

To see all of this brand’s ads on AdPharm, click here